Gene · 28882
Papers3,857
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,857
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic α2B Antagonist. | J Med Chem | 2023 | 36932954 | PubTator, text mining | PubMed |
| Remission Induction of IgG4-related Membranous Nephropathy with Multitarget Therapy. | Intern Med | 2023 | 36927975 | PubTator, text mining | PubMed |
| β1 and α2C-Adrenergic Receptor Polymorphisms Are Associated With Lower Incident Ventricular Fibrillation in Patients With ST-Segment-Elevation Myocardial Infarction. | J Am Heart Assoc | 2023 | 36927047 | PubTator, text mining | PubMed |
| Impact of Neuroeffector Adrenergic Receptor Polymorphisms on Incident Ventricular Fibrillation During Acute Myocardial Ischemia. | J Am Heart Assoc | 2023 | 36926933 | PubTator, text mining | PubMed |
| Marginalizing the genomic architecture to identify crosstalk across cancer and neurodegeneration. | Front Mol Neurosci | 2023 | 36923654 | PubTator, text mining | PubMed |
| New paradigms in purinergic receptor ligand discovery. | Neuropharmacology | 2023 | 36921890 | PubTator, text mining | PubMed |
| The role of the ATP-adenosine axis in ischemic stroke. | Semin Immunopathol | 2023 | 36917241 | PubTator, text mining | PubMed |
| Fibrinolytic Status and Risk of Death After Acute Pulmonary Embolism. | Clin Appl Thromb Hemost | 2023 | 36911974 | PubTator, text mining | PubMed |
| The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy. | Front Immunol | 2023 | 36911717 | PubTator, text mining | PubMed |
| Chronic caffeine consumption curbs rTMS-induced plasticity. | Front Psychiatry | 2023 | 36911138 | PubTator, text mining | PubMed |
| Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease. | Front Microbiol | 2023 | 36910207 | PubTator, text mining | PubMed |
| A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression. | Int J Mol Sci | 2023 | 36901855 | PubTator, text mining | PubMed |
| Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma. | World J Surg Oncol | 2023 | 36899373 | PubTator, text mining | PubMed |
| Mild inflammation impairs acute intermittent hypoxia-induced phrenic long-term facilitation by a spinal adenosine-dependent mechanism. | J Neurophysiol | 2023 | 36883762 | PubTator, text mining | PubMed |
| TIGIT signaling and its influence on T cell metabolism and immune cell function in the tumor microenvironment. | Front Oncol | 2023 | 36874131 | PubTator, text mining | PubMed |
| An update on the effect of intra-articular intervention strategies using nanomaterials in osteoarthritis: Possible clinical application. | Front Bioeng Biotechnol | 2023 | 36873347 | PubTator, text mining | PubMed |
| The pharmacogenetics of the new-generation antipsychotics - A scoping review focused on patients with severe psychiatric disorders. | Front Psychiatry | 2023 | 36873203 | PubTator, text mining | PubMed |
| Effects of theophylline on ADCY5 activation-From cellular studies to improved therapeutic options for ADCY5-related dyskinesia patients. | PLoS One | 2023 | 36867608 | PubTator, text mining | PubMed |
| Crystal diffraction prediction and partiality estimation using Gaussian basis functions. | Acta Crystallogr A Found Adv | 2023 | 36862040 | PubTator, text mining | PubMed |
| CD39/CD73/A2AR pathway and cancer immunotherapy. | Mol Cancer | 2023 | 36859386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28882/papers?page=17